Pfizer CEO Albert Bourla spoke with CNBC this week to discuss his company’s efforts to defeat COVID-19; saying “I think we will need a fourth dose” to combat new variants like Delta and Omicron.
“When we see real-world data, will determine if the omicron is well covered by the third dose and for how long. And the second point, I think we will need a fourth dose,” Bourla told CNBC’s “Squawk Box.”
“With omicron we need to wait and see because we have very little information. We may need it faster,” he added.
Read the full report at CNBC.